![Annalisa D’Andrea](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Annalisa D’Andrea
Director/Miembro de la Junta en
Engimmune Therapeutics AG
.
Perfil
Annalisa D’Andrea currently works at Engimmune Therapeutics AG, as Non-Executive Director from 2023 and Longwood Fund Management LLC, as Venture Partner from 2021.
Dr. D’Andrea also formerly worked at SRI International, as Executive Director & Head-Discovery Biology, Roche Holding AG, as Vice President & Global Head-Discovery, Kiniksa Pharmaceuticals Ltd., as Chief Scientific Officer, and ImmuneID, Inc., as President & Chief Scientific Officer.
Dr. D’Andrea received her doctorate degree from the University of Florence and undergraduate degree from the University of Siena.
Cargos activos de Annalisa D’Andrea
| Empresas | Cargo | Inicio |
|---|---|---|
Engimmune Therapeutics AG
 Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers | Director/Miembro de la Junta | 24/05/2023 |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Inversor de Capital Privado | 01/03/2021 |
Antiguos cargos conocidos de Annalisa D’Andrea.
| Empresas | Cargo | Fin |
|---|---|---|
ImmuneID, Inc.
 ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Presidente | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Director/Miembro de la Junta | - |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Director Técnico/Científico/I+D | - |
Formación de Annalisa D’Andrea.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
40
Relaciones de 1er grado
8
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
SRI International
SRI International Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Commercial Services |
University of Florence
 University of Florence Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Siena
 University of Siena Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund invests in companies located in the United States. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
ImmuneID, Inc.
ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
Engimmune Therapeutics AG
Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers | Health Technology |
- Bolsa de valores
- Insiders
- Annalisa D’Andrea
